Source: University at Buffalo
Date: August 14, 2008
Summary:
A novel gene signaling mechanism that controls whether a stem cell develops into its destined tissue or fails to differentiate and becomes cancer has been identified by researchers in the multi-laboratory Molecular and Structural Neurobiology and Gene Therapy Program based at the University at Buffalo. The new pathway, identified as Integrative FGFR1 Signaling (INFS), presents a new and promising target for in vivo neural stem cell therapies and anticancer strategies.
